Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Residual CardioVascular Risk (RCVR) After Percutaneous Coronary Intervention: A Prospective Study

NCT06619353 is registered in ClinicalTrials.gov with CHA University as lead sponsor.

NCT NCT06619353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06619353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Residual CardioVascular Risk (RCVR) After Percutaneous Coronary Intervention: A Prospective Study
Lead sponsor
CHA University
Phase
Observational
Overall status
Active, not recruiting
Start date
June 17, 2024
Completion date
February 28, 2029
Enrollment
500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease